NEW YORK, Dec. 15 (GenomeWeb News) - CombiMatrix and partner Nanomaterials Discovery Corporation have created a prototype workstation for the combinatorial discovery and development of new nanomaterials, the firms said today.
The news, which is considered a milestone by the partners, caused shares in CombiMatrix yesterday to close up 10.35 percent at $4.05 in unusually heavy volume.
Registering provides access to this and other free content.
Already have an account?Login Now.
The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.
Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.
Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.
In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.